Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the ordinary shares, NIS 0.20 par value and American Depositary Shares, each representing one (1) Ordinary Share, par value NIS 0.20 per share, of Evogene Ltd., a company organized under the laws of Israel. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
| July 10, 2026 | L.I.A. Pure Capital Ltd. | ||
| By: | /s/ Kfir Silberman | ||
| Name: | Kfir Silberman | ||
| Title: | Chairman and Chief Executive Officer | ||
| /s/ Kfir Silberman | |||
| Kfir Silberman | |||
| Invest Pro Shukai Hon Ltd. | |||
| By: | /s/ Eli Zamir | ||
| Name: | Eli Zamir | ||
| Title: | Director | ||
| /s/ Ron Yair Peled | |||
| Ron Yair Peled | |||
SCHEDULE A
Transactions in Securities of the Issuer Since the Filing of the Schedule 13D
Evogene Ltd.
| Reporting Person | Nature of the Transaction | Securities Purchased/ (Sold) | Price Per Security (US$) | Date of Purchase/ Sale | ||||||||
| L.I.A. Pure Capital Ltd. | Acquisition of a sufficient number of Ordinary Shares to enable the Reporting Persons to requisition a shareholders’ meeting for the purpose of proposing changes to the composition of the Company’s Board of Directors. | 1,470,000 | 0.49 | 07/10/2026 | ||||||||
| Invest Pro Shukai Hon Ltd. | Acquisition of a sufficient number of Ordinary Shares to enable the Reporting Persons to requisition a shareholders’ meeting for the purpose of proposing changes to the composition of the Company’s Board of Directors. | 500,000 | 0.49 | 07/10/2026 | ||||||||